<DOC>
	<DOCNO>NCT00743470</DOCNO>
	<brief_summary>The purpose study study safety , tolerability pharmacokinetics rifabutin dose lopinavir/ritonavir tablet healthy volunteer .</brief_summary>
	<brief_title>A Bioavailability Study Rifabutin Lopinavir/Ritonavir Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<criteria>Adult Male Female 1855 yr . Subject provide write consent . Subject general good health . If female , subject postmenopausal . If female , subject pregnant breastfeeding . Subject must use birth control method surgically sterile . Subject HAVIgM , HBsAg HIV Ab positive . Positive screen drug abuse , alcohol , smoking . Can medication , include counter drug . Can previous history alcohol drug abuse . Can history major disease disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>HIV co-infected tuberculosis</keyword>
</DOC>